Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4D | Q08499 | 2/20 | 1.00 |
| ▸ | PDE3A | Q14432 | 2/20 | 1.00 |
| ▸ | PNP | P00491 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 1.00 |
| ▸ | NT5E | P21589 | 1/20 | 0.67 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.62 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.62 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.62 |
| ▸ | PDE2A | O00408 | 1/20 | 0.62 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.62 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.57 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cladribine SCHEMBL2789344 | 1.00 | PDE4D (1.00) | PDE4DPDE3APNPLMNATP53 | |
| Cladribine SCHEMBL29881889 | 1.00 | PDE4D (1.00) | PDE4DPDE3APNPLMNATP53 | |
| Cladribine SCHEMBL11949489 | 1.00 | PDE4D (1.00) | PDE4DPDE3APNPLMNATP53 | |
| Cladribine SCHEMBL11948325 | 1.00 | PDE4D (1.00) | PDE4DPDE3APNPLMNATP53 | |
| Cladribine SCHEMBL4527409 | 1.00 | PDE4D (1.00) | PDE4DPDE3APNPLMNATP53 | |
| Cladribine SCHEMBL17367349 | 1.00 | PDE4D (1.00) | PDE4DPDE3APNPLMNATP53 | |
| Cladribine SCHEMBL7969581 | 1.00 | PDE4D (1.00) | PDE4DPDE3APNPLMNATP53 | |
| Cladribine SCHEMBL1697053 | 1.00 | PDE4D (1.00) | PDE4DPDE3APNPLMNATP53 | |
| Cladribine SCHEMBL21303677 | 1.00 | PDE4D (1.00) | PDE4DPDE3APNPLMNATP53 | |
| Cladribine SCHEMBL29355473 | 1.00 | PDE4D (1.00) | PDE4DPDE3APNPLMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 97826 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144879-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | AI-BIOPHARMA (FR) | 2026-05-28 | — | — | US | claimed |
| EP-3607938-B1 | PHARMACEUTICAL COMPOSITION | SOVIC BRKICIC LJILJANA (HR) | 2026-05-27 | — | — | EP | claimed |
| CN-116209439-B | Cereblon protein modulators | Saint Jude Children's Research Hospital Ltd. (US) | 2026-05-26 | — | — | CN | claimed |
| WO-2026107075-A1 | METHODS OF TREATING MULTIPLE SCLEROSIS WITH CD19-CD20 DUAL CAR-T CELLS | GENENTECH, INC. (US) | 2026-05-21 | — | — | WO | claimed |
| US-20260138973-A1 | SUBSTITUTED PYRIDINES FOR USE IN TREATING OR PREVENTING INFLAMMATORY DISEASES OR DISEASES ASSOCIATED WITH AN UNDESIRABLE IMMUNE RESPONSE | SITRYX THERAPEUTICS LTD (GB) | 2026-05-21 | — | — | US | claimed |
| WO-2026107377-A1 | PHARMACOLOGICAL RE-ACTIVATION OF MUTANT PVHL | KARANICOLAS JOHN (US) | 2026-05-21 | — | — | WO | claimed |
| US-20260137680-A1 | NOVEL COMPOUNDS | SITRYX THERAPEUTICS LTD (GB) | 2026-05-21 | — | — | US | claimed |
| WO-2026102563-A1 | DISUBSTITUTED PYRIMIDOPYRROLE ANALOG AND USE THEREOF | 深圳湾实验室坪山生物医药研发转化中心 | 2026-05-21 | — | — | WO | claimed |
| US-20260137674-A1 | COMBINATION THERAPY USING A KRAS G12D INHIBITOR, AND A NUCLEOSIDE ANALOG, AND/OR A MICROTUBULE INHIBITOR | INCYTE CORP (US) | 2026-05-21 | — | — | US | claimed |
| WO-2026105121-A1 | ANTICANCER FORMULATIONS AND USES THEREOF | INTRAGEL THERAPEUTICS LTD. (IL) | 2026-05-21 | — | — | WO | claimed |
| EP-0364559-A4 | SUBSTITUTED ADENINE DERIVATIVES USEFUL AS THERAPEUTIC AGENTS | — | 1991-01-09 | — | — | EP | claimed |
| EP-0190726-B1 | NOVEL DEOXYADENOSINE PHOSPHATE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | WARNER-LAMBERT COMPANY (US) | 1990-06-13 | — | — | EP | claimed |
| EP-0364559-A1 | SUBSTITUTED ADENINE DERIVATIVES USEFUL AS THERAPEUTIC AGENTS. | SCRIPPS CLINIC RES (US) | 1990-04-25 | — | — | EP | claimed |
| EP-0351795-A2 | Novel deoxyadenosine compounds and methods of making and using the same | WARNER-LAMBERT COMPANY (US) | 1990-01-24 | — | — | EP | claimed |
| EP-0350287-A2 | Lipid derivatives of antiviral nucleosides, liposomal incorporation and method of use | NeXstar Pharmaceuticals, Inc. (US) | 1990-01-10 | — | — | EP | claimed |
| EP-0173059-B1 | METHOD FOR THE PRODUCTION OF 2'-DEOXYADENOSINE COMPOUNDS | BRIGHAM YOUNG UNIVERSITY (US) | 1989-11-29 | — | — | EP | claimed |
| WO-1989008658-A1 | SUBSTITUTED ADENINE DERIVATIVES USEFUL AS THERAPEUTIC AGENTS | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1989-09-21 | — | — | WO | claimed |
| US-4760137-A | Method for the production of 2'-deoxyadenosine compounds | BRIGHAM YOUNG UNIVERSITY (US) | 1988-07-26 | — | — | US | claimed |
| EP-0190726-A2 | Novel deoxyadenosine phosphate compounds and methods of making and using the same | WARNER-LAMBERT COMPANY (US) | 1986-08-13 | — | — | EP | claimed |
| EP-0173059-A2 | Method for the production of 2'-deoxyadenosine compounds | BRIGHAM YOUNG UNIVERSITY (US) | 1986-03-05 | — | — | EP | claimed |